Arcus Biosciences News and Activities

Arcus Biosciences is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Arcus Biosciences is a company listed under the stock ticker RCUS (US).

View the org chart displaying its 30 main executives

Most searched biographies at Arcus Biosciences

• Terry Rosen, Chief Executive Officer and Director
• Merdad Parsey, Director
• Patrick Machado, Director

Create your alert
to follow the executive moves at Arcus Biosciences.

Arcus Biosciences has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Arcus Biosciences

• Arcus Biosciences to Participate in Two Upcoming Investor Conferences
• Arcus Biosciences Announces Commencement of Public Offering of Common Stock
• Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
• Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update
• Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
• Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study
• Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event
• Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation
• Arcus Biosciences to Participate in Three Upcoming Investor Conferences
• Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
• View more press releases Close

Social media about Arcus Biosciences

• Arcus Biosciences on Wikipedia, Google News & Yahoo Finance
• Arcus Biosciences on LinkedIn, X (Twitter) & YouTube